查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1460121

大肠镜检查设备市场- 按产品类型（大肠镜、视觉化系统）、应用（结直肠癌、林奇症候群、溃疡性结肠炎、克隆氏症）、最终用途（医院、门诊手术中心） - 全球预测，2024 - 2032 年

Colonoscopy Devices Market - By Product Type (Colonoscope, Visualization Systems), Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohns Disease), End-use (Hospitals, Ambulatory Surgical Centers) - Global Forecast, 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于全球大肠直肠癌发生率不断上升，2024 年至 2032 年大肠镜检查设备市场规模预计将以 5% 的复合CAGR成长。

根据世界卫生组织的数据，大肠直肠癌是世界上第三大常见疾病，约占所有癌症诊断的 10%，也是癌症相关死亡的第二大原因。随着全球人口迅速老化和生活方式的改变，大肠癌的盛行率将继续上升，从而推动对大肠镜检查程序和设备的需求。此外，大肠镜检查设备的先进技术，例如改进的成像和导航系统，正在提高诊断准确性，进一步加速产业成长。例如，2024年2月，Magentiq推出了人工智慧辅助大肠镜检查工具，将腺瘤的识别和切除率提高了7%，降低了罹患结直肠癌的几​​率。

大肠镜检查设备产业按产品类型、应用、最终用途和地区进行细分。

就产品类型而言，预计2024-2032年可视化系统领域的市值复合CAGR为4.9%。高清 (HD) 和超高清 (UHD) 摄影机等创新以及窄带成像 (NBI) 和虚拟色素内视镜技术正在增强结直肠疾病的检测和诊断。这些先进的可视化系统可提供更清晰、详细的结肠影像，从而提高病变识别的准确性并降低漏诊率。此外，人工智慧辅助影像分析的整合进一步增强了诊断能力，显着提高了产品的接受度。

根据应用情况，预计到 2032 年，林奇症候群细分市场的大肠镜检查设备市场复合CAGR将达到4.6%。林奇症候群(LS) 是最常见的遗传性大肠直肠癌(CRC)疾病，其人群频率为 2% 至3%。%。这种疾病的渗透使得对定期大肠镜检查以进行早期发现和监测的需求激增。林奇症候群的盛行率不断上升，加上人们的认识和基因检测的不断提高，推动了对用于有效筛检和监测的大肠镜检查设备的需求。色素内视镜和高清成像等先进技术也提高了对林奇症候群患者至关重要的病变检出率，从而促进了该细分市场的成长。

从地区来看，亚太地区大肠镜检查设备产业预计 2024 年至 2032 年将呈现 6.2% 的成长率。人们对大肠直肠癌的认识不断提高，加上医疗保健支出不断增加，刺激了对大肠镜检查的需求。政府不断努力改善医疗基础设施，从而促进预防性医疗保健。此外，该地区人口老化和饮食习惯的变化导致大肠直肠疾病的增加，需要更多的筛检程序。此外，医疗技术的进步和微创手术的广泛采用也推动了区域市场的扩张。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 对微创手术的需求不断增长
      • 技术进步
      • 大肠直肠癌的发生率和盛行率不断增加
    • 产业陷阱与挑战
      • 与大肠镜检查程序相关的风险
  • 成长潜力分析
  • 波特的分析
  • PESTEL分析
  • 报销场景
  • 监管环境
  • 技术景观
  • 未来市场趋势
  • 缺口分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品类型，2018 年 - 2032 年

  • 主要趋势
  • 大肠镜
  • 可视化系统
  • 其他产品类型

第 6 章：市场估计与预测：按应用分类，2018 年 - 2032 年

  • 主要趋势
  • 大肠直肠癌
  • 林奇综合症
  • 溃疡性结肠炎
  • 克罗恩病
  • 其他应用

第 7 章：市场估计与预测：按最终用途，2018 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 9 章：公司简介

  • Endomed Systems
  • Fujifilm Holdings Corporation
  • GI-View
  • Medtronic plc
  • Olympus Corporation
  • Ottomed Endoscopy
  • PENTAX Medical
  • Smart Medical Systems Ltd.
  • Steris PLC
  • Stryker Corporation
简介目录
Product Code: 4162

Colonoscopy Devices Market size is poised to expand at 5% CAGR from 2024 to 2032 driven by the increasing incidence of colorectal cancer worldwide.

As per WHO, colorectal cancer is the third most frequent disease in the world, accounting for around 10% of all cancer diagnoses, and the second biggest cause of cancer-related fatalities. With the rapidly aging global population and lifestyle changes, the prevalence of colorectal cancer will continue to rise, fueling the demand for colonoscopy procedures and devices. Additionally, advanced technologies in colonoscopy devices, such as improved imaging and navigation systems are enhancing diagnostic accuracy, further accelerating the industry growth. For instance, in February 2024, Magentiq launched its AI-aided colonoscopy tool to improve the identification and removal of adenomas by 7%, lowering the chance of getting colorectal cancer.

The colonoscopy devices industry is segmented in product type, application, end-use, and region.

In terms of product type, the market value from the visualization systems segment is anticipated to witness 4.9% CAGR from 2024-2032. Innovations, such as high-definition (HD) and ultra-high-definition (UHD) cameras, along with narrow-band imaging (NBI) and virtual chromoendoscopy technologies are enhancing the detection and diagnosis of colorectal diseases. These advanced visualization systems offer clearer, detailed images of the colon for improving accuracy in lesion identification and reducing miss rates. Additionally, the integration of AI-assisted image analysis is further augmenting the diagnostic capabilities, fueling the product acceptance significantly.

Based on application, the colonoscopy devices market from the Lynch syndrome segment is projected to record 4.6% CAGR through 2032. Lynch syndrome (LS) is the most prevalent hereditary colorectal cancer (CRC) condition, with a population frequency ranging from 2% to 3%. This disease penetration is surging the need for regular colonoscopies for early detection and surveillance. The rising prevalence of Lynch Syndrome, coupled with increasing awareness and genetic testing is driving the demand for colonoscopy devices tailored for effective screening and monitoring. Advanced technologies, such as chromoendoscopy and high-definition imaging are also enhancing the rate of lesion detection crucial for Lynch Syndrome patients, boosting the segment growth.

Regionally, the Asia Pacific colonoscopy devices industry is projected to exhibit 6.2% growth rate from 2024-2032. The increasing awareness about colorectal cancer coupled with rising healthcare expenditures are fueling the demand for colonoscopy procedures. The growing government efforts to improve healthcare infrastructure is promoting preventive healthcare. Additionally, the aging population and changing dietary habits in the region are contributing to the rise in colorectal diseases, necessitating more screening procedures. Moreover, advancements in medical technologies and the higher adoption of minimally invasive procedures are also driving the regional market expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising demand for minimally invasive procedures
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Increasing incidence and prevalence of colorectal cancer
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Risk associated with colonoscopy procedures
  • 3.3 Growth potential analysis
  • 3.4 Porter's analysis
    • 3.4.1 Supplier power
    • 3.4.2 Buyer power
    • 3.4.3 Threat of new entrants
    • 3.4.4 Threat of substitutes
    • 3.4.5 Industry rivalry
  • 3.5 PESTEL analysis
  • 3.6 Reimbursement scenario
  • 3.7 Regulatory landscape
  • 3.8 Technological landscape
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Colonoscope
  • 5.3 Visualization systems
  • 5.4 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Colorectal cancer
  • 6.3 Lynch syndrome
  • 6.4 Ulcerative colitis
  • 6.5 Crohn's disease
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Endomed Systems
  • 9.2 Fujifilm Holdings Corporation
  • 9.3 GI-View
  • 9.4 Medtronic plc
  • 9.5 Olympus Corporation
  • 9.6 Ottomed Endoscopy
  • 9.7 PENTAX Medical
  • 9.8 Smart Medical Systems Ltd.
  • 9.9 Steris PLC
  • 9.10 Stryker Corporation